Rite Aid Corporation (RAD) Stock Analysis
DELISTED 2023
What happened to Rite Aid Corporation (RAD) stock?
Rite Aid Corporation (RAD) no longer trades on public markets. It was delisted in October 2023. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Rite Aid Corporation (RAD) trades at $0.6483. Rite Aid Corporation operates a chain of retail drugstores in the United States, providing prescription drugs, pharmacy services, and a variety of retail products. Market cap: $36.8M, Sector: Healthcare.
Last analyzed: May 10, 2026Analyst Coverage for RAD: RAD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RAD against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
RAD: 1/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Rite Aid Corporation (RAD) Healthcare & Pipeline Overview
Rite Aid Corporation, a major player in the U.S. retail pharmacy sector, operates approximately 2,450 retail pharmacy locations across 17 states. The company distinguishes itself through its integrated pharmacy benefit management (PBM) offerings and healthcare services, but faces challenges in a competitive market with established national players.
What Is the Investment Thesis for RAD?
Rite Aid Corporation presents a complex investment case. While the company benefits from its established retail pharmacy network and integrated PBM services, its negative profit margin of -3.1% raises concerns about profitability. Growth catalysts include expanding healthcare services within its retail locations and leveraging its PBM offerings to capture a larger share of the pharmacy benefits market. However, potential risks include intense competition from larger pharmacy chains, evolving healthcare regulations, and the need to manage debt effectively. Investors should closely monitor Rite Aid's ability to improve its financial performance and capitalize on growth opportunities in the evolving healthcare landscape. The company's beta of 1.29 indicates higher volatility compared to the market.
Based on FMP financials and quantitative analysis
RAD Key Highlights
Operates 2,450 retail pharmacy locations across 17 states as of February 26, 2022, providing a significant retail footprint.
- Offers an integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions and specialty pharmacy services.
- Provides healthcare services such as immunizations and chronic disease management within its retail pharmacies.
- Generated revenue through two segments: Retail Pharmacy and Pharmacy Services.
- Faces a negative profit margin of -3.1%, indicating challenges in achieving profitability.
Who Are RAD's Competitors?
RAD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CVS CVS Health Corporation | $93.65 | +0.00% | $119B | 70 |
| WBA Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company | $11.98 | +0.50% | $10.4B | 45 |
| MYCOF Noveris Health Sciences Inc. | $0.73 | +0.00% | $42.7M | 48 |
| YI 111, Inc. | $3.44 | -1.99% | $30.1M | 44 |
| LFLY Leafly Holdings, Inc. | $37.00 | +0.00% | $115M | 50 |
| HITI High Tide Inc. | $2.42 | -1.42% | $213M | 47 |
| HEWA HealthWarehouse.com, Inc. | $0.11 | +0.00% | $6.29M | 55 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $0.65 | +0.00% | $543M | 55 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RAD's Key Strengths?
Established retail pharmacy network.
- Integrated pharmacy benefit management (PBM) services.
- Healthcare service offerings within retail pharmacies.
- Brand recognition and customer loyalty.
What Are RAD's Weaknesses?
Negative profit margin.
- High debt levels.
- Intense competition from larger pharmacy chains.
- Limited geographic reach compared to national competitors.
What Could Drive RAD Stock Higher?
Expansion of healthcare service offerings within retail pharmacies.
- Implementation of new technologies to improve operational efficiency.
- Efforts to optimize the retail pharmacy network and reduce costs.
What Are the Key Risks for RAD?
Financial-distress signal — its Altman Z-Score of 0.69 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Increasing competition from online pharmacies and larger retail chains.
- Evolving healthcare regulations affecting drug pricing and reimbursement.
- High debt levels and financial performance pressures.
- Economic downturn impacting consumer spending on healthcare and retail products.
What Are the Growth Opportunities for RAD?
- Expansion of Healthcare Services: Rite Aid can expand its healthcare service offerings within its retail pharmacies, such as chronic disease management programs, telehealth services, and preventative care. The market for these services is growing as healthcare providers focus on value-based care and preventative medicine. By offering a wider range of healthcare services, Rite Aid can attract new customers, increase revenue per customer, and improve patient outcomes. This expansion could be implemented over the next 3-5 years.
- Leveraging Pharmacy Benefit Management (PBM) Offerings: Rite Aid's Pharmacy Services segment provides an opportunity to capture a larger share of the PBM market. The PBM market is expected to grow as employers and health plans seek to manage drug costs and improve medication adherence. By enhancing its technology solutions, expanding its network of pharmacies, and offering competitive pricing, Rite Aid can attract new PBM clients and increase its market share. This growth can be realized within the next 2-3 years.
- Strategic Partnerships and Acquisitions: Rite Aid can pursue strategic partnerships and acquisitions to expand its geographic reach, enhance its service offerings, and gain access to new technologies. For example, the company could partner with healthcare providers or technology companies to offer integrated healthcare solutions. Strategic acquisitions could help Rite Aid expand into new markets or acquire specialized capabilities. These initiatives can be pursued over the next 3-5 years.
- Enhancing Customer Loyalty Programs: Rite Aid can enhance its customer loyalty programs to increase customer retention and drive sales. By offering personalized rewards, exclusive discounts, and targeted promotions, Rite Aid can encourage customers to shop more frequently and spend more per visit. The company can also leverage data analytics to better understand customer preferences and tailor its offerings accordingly. These enhancements can be implemented within the next year.
- Focus on Specialty Pharmacy Services: The specialty pharmacy market is growing rapidly, driven by the increasing use of specialty drugs for chronic and complex conditions. Rite Aid can focus on expanding its specialty pharmacy services, such as providing medication management, patient education, and adherence support. By offering specialized services and expertise, Rite Aid can attract patients with complex medical needs and capture a larger share of the specialty pharmacy market. This expansion can be pursued over the next 2-4 years.
What Are RAD's Competitive Advantages?
- Established Retail Pharmacy Network: Rite Aid has a significant retail footprint with approximately 2,450 locations across 17 states, providing convenient access to prescription drugs and healthcare services.
- Integrated Pharmacy Benefit Management (PBM) Services: Rite Aid offers a comprehensive suite of PBM services, including technology solutions, mail delivery, and specialty pharmacy, providing a competitive advantage in managing drug costs and utilization.
- Healthcare Service Offerings: Rite Aid provides healthcare services such as immunizations and chronic disease management, differentiating itself from traditional retail pharmacies and attracting customers seeking convenient healthcare solutions.
What Does RAD Do?
Founded in 1962 and headquartered in Philadelphia, Pennsylvania, Rite Aid Corporation has evolved into a significant retail drugstore chain in the United States. The company operates through two primary segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment focuses on dispensing prescription drugs and providing a wide array of over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food, beverages, and pet care products. This segment also operates retail pharmacies and clinics, offering healthcare services such as immunizations, blood pressure monitoring, cholesterol and diabetes assistance, and guidance on obesity and tobacco addiction. The Pharmacy Services segment delivers an integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy services, network and rebate administration, claims adjudication, and pharmacy discount programs. These services cater to health plans, commercial employers, labor groups, and state and local governments, including drug benefits under Medicare Part D. As of February 26, 2022, Rite Aid operated 2,450 retail pharmacy locations across 17 states, positioning itself as a key player in the retail pharmacy and pharmacy services landscape.
What Products and Services Does RAD Offer?
- Operates retail drugstores.
- Sells prescription drugs.
- Provides pharmacy services.
- Offers over-the-counter medications.
- Sells health and beauty aids.
- Provides pharmacy benefit management (PBM) services.
How Does RAD Make Money?
- Generates revenue from the sale of prescription drugs and over-the-counter medications.
- Earns fees for providing pharmacy services, such as immunizations and medication counseling.
- Receives payments for providing PBM services to health plans and employers.
- Sells a variety of retail products, including health and beauty aids, personal care items, and household goods.
What Industry Does RAD Operate In?
Rite Aid operates within the competitive retail pharmacy and pharmacy benefit management (PBM) industries. The U.S. pharmacy market is characterized by increasing demand for prescription drugs and healthcare services, driven by an aging population and rising healthcare costs. Key trends include the expansion of pharmacy services, such as immunizations and chronic disease management, and the growing importance of PBMs in managing drug costs and utilization. Rite Aid competes with larger national chains like CVS and Walgreens, as well as regional players and online pharmacies. The company's success depends on its ability to differentiate its services, manage costs, and adapt to evolving healthcare regulations.
Who Are RAD's Key Customers?
- Individual consumers who purchase prescription drugs and retail products.
- Health plans that contract with Rite Aid for PBM services.
- Employers who offer pharmacy benefits to their employees through Rite Aid's PBM services.
- Government entities that utilize Rite Aid's pharmacy services for Medicare Part D and other programs.
Financial Health
Rite Aid Corporation's Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.69 places it in the distress zone, a signal of elevated financial risk.
RAD Valuation & Market Position
With a $36.8M market cap, Rite Aid Corporation sits in the micro-cap segment of the market.
Key Financial Metrics
Return on equity for Rite Aid Corporation stands at 276.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -10.0%, showing how much profit it generates from its asset base. A current ratio of 1.21 indicates the company holds enough short-term assets to cover its near-term obligations.
Company Profile
Rite Aid Corporation operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Philadelphia, US. The company is led by CEO Elizabeth H. Burr. RAD has traded publicly since 1980.
RAD Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Rite Aid's recent restructuring efforts might finally be gaining traction, with insiders potentially seeing value where the market doesn't.
- Community chatter suggests a growing belief that the worst is over for Rite Aid, with some seeing it as a potential turnaround play.
- The market might be underestimating Rite Aid's ability to adapt to the changing pharmacy landscape, especially with its focus on health and wellness services.
- There's a sense among some traders that Rite Aid's brand recognition and established customer base could be a solid foundation for future growth.
Bear Case
- Insider activity, even if positive, might not be enough to offset the company's significant debt burden and ongoing financial challenges.
- Community sentiment, while showing glimmers of hope, is still largely negative due to concerns about bankruptcy and dilution.
- The market perception of Rite Aid remains weak, with many investors viewing it as a distressed asset with limited upside potential.
- Rite Aid faces intense competition from larger pharmacy chains and online retailers, making it difficult to regain market share and profitability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RAD Latest News
-
Stocks That Hit 52-Week Lows On Friday
· Aug 16, 2019
Leadership: Elizabeth H. Burr
Chief Executive Officer
Elizabeth H. Burr is the Chief Executive Officer of Rite Aid Corporation. Her background includes extensive experience in the retail and healthcare sectors. Prior to joining Rite Aid, she held leadership positions at various companies, focusing on strategic planning, operational efficiency, and business development. She is known for her expertise in driving growth and innovation in complex business environments. Her educational background includes a degree in Business Administration.
Track Record: Since assuming the role of CEO, Elizabeth H. Burr has focused on streamlining operations, enhancing customer experience, and expanding healthcare service offerings. Key initiatives include optimizing the retail pharmacy network, improving PBM performance, and implementing new technologies to enhance efficiency. Her leadership has been instrumental in navigating the challenges of a competitive market and positioning Rite Aid for future growth.
What Investors Ask About Rite Aid Corporation (RAD) — Healthcare
What happened to Rite Aid Corporation (RAD) stock?
Rite Aid Corporation (RAD) no longer trades on public markets. It was delisted in October 2023. The figures below are historical and are not a current quote.
Can I still buy RAD shares?
No. RAD stopped trading on public markets in October 2023, so the shares are not available through a broker. Anything you see quoted for RAD elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before RAD stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Rite Aid Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does Rite Aid Corporation do?
Rite Aid Corporation operates as a retail drugstore chain in the United States, providing prescription drugs, over-the-counter medications, and a variety of retail products. The company operates through two segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment focuses on dispensing medications and offering healthcare services such as immunizations and chronic disease management.
What do analysts say about RAD stock?
Analyst consensus on RAD stock is mixed, reflecting the company's complex financial situation and competitive landscape. Key valuation metrics, such as price-to-earnings and price-to-sales ratios, are influenced by Rite Aid's negative profit margin and high debt levels. Growth considerations include the company's ability to expand its healthcare service offerings and improve PBM performance. Investors should conduct thorough due diligence and consider the potential risks and opportunities before making investment decisions.
What are the main risks for RAD?
The main risks for Rite Aid Corporation include intense competition from larger pharmacy chains and online retailers, evolving healthcare regulations affecting drug pricing and reimbursement, and high debt levels that constrain financial flexibility. The company also faces the risk of economic downturn impacting consumer spending on healthcare and retail products. Effective management of these risks is crucial for Rite Aid's long-term success and financial stability.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Market conditions and competitive landscape are subject to change.